New
IDNAPTEX range
Ready-to-use dPCR assays
Simultaneous detection of mutations in cDNA and DNA
Optimized for
QIAcuity® nanoplate based Digital PCR system
EASY TO USE
Ready-to-use mix of probes and primers.
Up to 23 targets in a single reaction
FAST
Results in
less than 4 hours
RELIABLE
Target controls included
PRECISE
ID SOLUTIONS
Patented technology*
OPTIMIZED
Universal amplification program for all tests on QIAcuity® 5Plex digital PCR system
A highly multiplexed solution
IDNAPTEX products accurately detect target mutations from plasma (cfDNA) or FFPE tissue (gDNA) using an innovative multiplexed solution.
These assays are based on an optimized mix of primers and fluorescent probes, guaranteeing simultaneous amplification of multiple target mutations in a single well.
Universal amplification program compatible with all tests
Designed for simplicity of use and reproducibility of results, reagents are supplied in pre-mixed tubes with ready-to-use primers and probes, plus Target Process Control (TPC).
Combined with the QIAcuity 5Plex dPCR system, the streamlined workflow enables results to be obtained in less than a day, providing a high-performance solution for clinical oncology research.
Accurate detection of mutations
Combined with assays from the IDNAPTEX range, the patented* ID-ICE reagent acts as an internal control, specially designed to assess the extraction efficiency of liquid biopsy samples.
This technology guarantees optimal monitoring of the entire pre-analytical process, reinforcing the reliability of the results obtained.
Explore our catalog of innovative digital PCR assays
IDNAPTEX ESR1
Primers and Probes set for ESR1 mutations detection
- L536H, L536P, L536R, L536Q, L536F, Y537S, Y537C, Y537N, Y537D, Y537H, D538G, E380Q
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX H3F3A
Primers and Probes set for H3F3A mutations detection
- K27M, G34R, G34V
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX BRAF
Primers and Probes set for BRAF mutations detection
- L597S, L597Q, L597R, L597V, A598V, A598T, V600K, V600R, V600M, V600G, V600D, K601E, V600E
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX BRAF-CNS
Primers and Probes set for BRAF mutations detection
- V600E, KIAA1549-BRAF fusion
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX EGFR SENSI
Primers and Probes set for EGFR mutations detection
- L858R, exon 19 deletions
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX EGFR RESIST
Primers and Probes set for EGFR mutations detection
- C797S, T790M
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX KRAS G12C
Primers and Probes set for KRAS G12C mutation detection
- G12C
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX KRAS 3X
Primers and Probes set for KRAS mutations detection on exon 2, 3 and 4
- Q61X, G12X, G13X, K117N, A146X
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX NRAS
Primers and Probes set for NRAS mutations detection
- Q61X, G12X, G13X
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX FGFR1-CNS
Primers and Probes set for FGFR1 mutations detection and Exons 11 to 18 duplication detection
- N546K, K656E, Duplication Exons 11 à 18
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX TERT
Primers and Probes set for TERT mutations detection
- C228T, C250T
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 96 tests
IDNAPTEX TERT
Primers and Probes set for TERT mutations detection
- C228T, C250T
- ADN libre circulant (cfDNA) extrait à partir de plasma ou ADN génomique (gDNA) isolé à partir de tissus fixés en formol et inclus en paraffine (FFPE)
- 24 réactions
Associated products
ID-ICE
Internal control of extraction
- Circulating free DNA (cfDNA) extracted from plasma
- 96 tests
IDNAPTEX EGFR RESIST
Système de distinction des mutations du gène BRAF dans le système nerveux central
- V600E et fusion de KIAA1549-BRAF
- Circulating free DNA (cfDNA) extracted from plasma or genomic DNA (gDNA) isolated from formalin-fixed, paraffin-embedded tissue (FFPE)
- 24 tests
*ID-ICE can be ordered separately. The patented ID SOLUTIONS technology is protected in Europe by patent number EP 3565902 and in the United States by patent number 12049664.
QIAcuity is a registered trademark of QIAGEN. QIAcuity dPCR instruments, consumables, and tests are sold by QIAGEN under license from Bio-Rad Laboratories, Inc. for use on QIAcuity Digital PCR instruments and exclude rights for pediatric applications.
QIAcuity is intended for molecular biology applications. This product is not intended for use in the diagnosis, prevention, or treatment of disease. Therefore, the performance characteristics of the product for clinical use (i.e., diagnostic, prognostic, therapeutic, or blood banking) are unknown.
Trademarks: QIAGEN®, QIAcuity®. Registered names, trademarks, etc. used in this document, even if not specifically marked as such, may be protected by law.
ID SOLUTIONS and IDNAPTEX are registered trademarks of ID SOLUTIONS.
